Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group
- PMID: 8299077
- DOI: 10.1002/1097-0142(19940201)73:3<556::aid-cncr2820730310>3.0.co;2-8
Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group
Abstract
Background: To increase the knowledge about the palliative effects of chemotherapy in patients with symptomatic advanced colorectal cancer, physician- and patient-rated "quality of life" was studied in a randomized multicenter trial comparing a regimen of methotrexate/5-fluorouracil (5-FU) followed by leucovorin rescue (MFL) with a regimen of 5-FU/leucovorin (FLV).
Methods: Between January 1989 and December 1990, 70 patients completed a quality of life questionnaire at randomization and after every fourth treatment course. At one of the hospitals, the evaluation was done as an interview (interview group, n = 24), whereas a questionnaire was used at the other hospitals (questionnaire group, n = 46).
Results: Objective responses (complete response plus partial response) were obtained in 15 (21%) patients, subjective responses in 29 (41%) patients, and an overall improved quality of life in 25 (36%) patients. In addition, 16 (23%) patients had unchanged quality of life during at least 4 months. There was a correlation between objective responses, subjective responses, and improvements in quality of life, although discrepancies were noticed, particularly in patients with only slight symptoms. Response rates were higher in the interview group than in the questionnaire group (P < 0.01). This difference could be related to a more favorable outcome when 5-FU was given as a bolus injection, rather than as a short-term infusion (more than 5 minutes).
Conclusions: Improvements or prolonged stabilization of disease in quality of life can be achieved in at least half of the patients with tumor-related symptoms. However, factors related to the administration of chemotherapy may influence this proportion.
Similar articles
-
Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.Ann Oncol. 1993 Mar;4(3):235-40. doi: 10.1093/oxfordjournals.annonc.a058463. Ann Oncol. 1993. PMID: 8471555 Clinical Trial.
-
Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens.Eur J Cancer Clin Oncol. 1989 May;25(5):829-35. doi: 10.1016/0277-5379(89)90128-4. Eur J Cancer Clin Oncol. 1989. PMID: 2472275 Clinical Trial.
-
Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.Anticancer Res. 1995 Nov-Dec;15(6B):2679-82. Anticancer Res. 1995. PMID: 8669846
-
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.J Clin Oncol. 1989 Oct;7(10):1407-18. doi: 10.1200/JCO.1989.7.10.1407. J Clin Oncol. 1989. PMID: 2476530 Review.
-
Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):28-34. Oncology (Williston Park). 1998. PMID: 9830622 Review.
Cited by
-
Alternative metrics for assessing clinical benefit with immunotherapy in oncology.Oncoimmunology. 2018 May 7;8(10):e1343774. doi: 10.1080/2162402X.2017.1343774. eCollection 2019. Oncoimmunology. 2018. PMID: 31646068 Free PMC article.
-
[Anticancer therapy for symptom relief? : A systematic review of clinical trials in oncology].Schmerz. 2018 Apr;32(2):90-98. doi: 10.1007/s00482-018-0270-1. Schmerz. 2018. PMID: 29411116 German.
-
Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung Cancer.Oncologist. 2018 Apr;23(4):489-495. doi: 10.1634/theoncologist.2017-0187. Epub 2017 Dec 6. Oncologist. 2018. PMID: 29212735 Free PMC article.
-
Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up.Support Care Cancer. 2016 Apr;24(4):1463-71. doi: 10.1007/s00520-015-2931-2. Epub 2015 Sep 9. Support Care Cancer. 2016. PMID: 26349575
-
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study.Support Care Cancer. 2016 Feb;24(2):667-674. doi: 10.1007/s00520-015-2828-0. Epub 2015 Jul 1. Support Care Cancer. 2016. PMID: 26123602